interferon
ifn
inhibit
sever
acut
respiratori
syndrom
coronaviru
sarscov
replic
might
valuabl
sar
treatment
studi
demonstr
treatment
vero
cell
decreas
suscept
cell
sarscov
infect
contrast
ifn
show
antivir
activ
administ
immedi
sarscov
infect
suggest
act
earli
sarscov
replic
cycl
inde
bind
recombin
sarscov
spike
protein
vero
cell
diminish
cell
treat
also
cell
expos
consist
observ
downregul
cell
surfac
express
angiotensinconvert
enzym
sarscov
receptor
besid
diminish
cell
surfac
express
mrna
level
also
decreas
treatment
cytokin
find
suggest
inhibit
sarscov
replic
partli
downregul
sever
acut
respiratori
syndrom
sar
emerg
late
guangdong
provinc
china
spread
rapidli
sever
countri
asia
north
america
europ
caus
diseas
almost
peopl
nearli
die
month
first
emerg
sar
newli
discov
coronaviru
cov
identifi
etiolog
agent
ksiazek
et
al
peiri
et
al
sarscov
posit
strand
rna
viru
genom
kb
length
structur
similar
group
coronavirus
marra
et
al
rota
et
al
snijder
et
al
enter
host
cell
bind
spike
protein
domain
angiotensinconvert
enzym
sarscov
receptor
subsequ
domain
fuse
cellular
membran
liu
et
al
compon
reninangiotensin
system
mainli
involv
regul
heart
function
blood
pressur
boehm
nabel
crackow
et
al
express
vascular
endothelia
heart
kidney
testi
also
epithelia
small
intestin
alveolar
epitheli
cell
donoghu
et
al
ham
et
al
harmer
et
al
recent
shown
also
act
receptor
human
coronaviru
hofmann
et
al
sarscov
replic
predominantli
lower
respiratori
tract
caus
diffus
alveolar
damag
lead
sever
respiratori
distress
kuiken
et
al
nichol
et
al
treatment
sar
patient
mainli
base
use
ribavirin
corticosteroid
efficaci
drug
proven
sever
group
examin
antivir
effect
interferon
ifn
sarscov
vitro
studi
shown
human
recombin
ifn
inhibit
sarscov
replic
combin
synergist
antivir
effect
viru
morgenstern
et
al
sainz
et
al
furthermor
demonstr
pegyl
protect
pneumocyt
infect
sarscov
cynomolg
macaqu
haagman
et
al
usual
ifn
achiev
antivir
effect
induct
vero
cell
treat
ngml
combin
infect
sarscov
herp
simplex
viru
hsv
treatment
fig
data
shown
antivir
effect
sarscov
pretreat
fig
combin
fig
dose
depend
reduc
number
infect
cell
per
well
infect
either
one
virus
demonstr
previous
feduchi
et
al
surprisingli
recombin
human
also
exert
sarscov
antivir
activ
observ
hsv
infect
fig
suggest
virusspecif
antivir
activ
also
test
antivir
activ
anoth
coronaviru
also
use
receptor
enter
cell
hofmann
et
al
compar
untreat
control
cell
viral
excret
infect
vero
cell
reduc
log
treatment
fig
evalu
antivir
effect
sarscov
use
sarscovspecif
rtpcr
plaqu
titrat
vero
cell
pretreat
cell
ngml
h
subsequ
infect
excret
sarscov
treat
cell
diminish
log
sarscov
rna
level
cell
antivir
effect
abrog
preincub
neutral
antibodi
fig
b
result
demonstr
modest
antivir
activ
sarscov
infect
vero
cell
determin
step
sarscov
life
cycl
affect
condit
medium
vero
cell
treat
ngml
remov
cell
wash
infect
sarscov
remov
condit
medium
vero
cell
h
treatment
still
confer
protect
sarscov
fig
hand
condit
medium
transfer
fresh
untreat
vero
cell
cultur
infect
min
later
ad
tcid
sarscov
medium
reduct
number
sarscov
infect
cell
observ
fig
therefor
presenc
solubl
sarscovinfect
block
molecul
releas
cell
unlik
residu
still
present
condit
medium
shown
probabl
inhibit
replic
sarscov
enter
cell
need
ad
cell
earlier
time
point
thu
like
antivir
effect
earli
step
sarscov
life
cycl
vero
cell
sinc
treatment
reduc
excret
viru
viral
replic
infect
administ
sarscov
infect
bind
sarscov
protein
cytokinetr
vero
cell
analyz
use
flow
cytometri
shown
fig
treatment
reduc
abil
vero
cell
bind
recombin
protein
combin
also
reduc
suscept
vero
cell
sarscov
analyz
bind
protein
cell
treatment
demonstr
ngml
reduc
bind
capac
protein
background
level
fig
data
suggest
cytokin
influenc
express
cellular
receptor
sarscov
examin
decreas
suscept
sarscov
infect
effect
cell
surfac
express
analyz
express
cytokin
treatment
shown
fig
ngml
downregul
express
preincub
neutral
antibodi
abolish
effect
fig
similarli
treatment
vero
cell
ngml
also
express
inhibit
sarscov
replic
data
shown
background
stain
determin
incub
cell
normal
goat
serum
follow
secondari
antibodi
fig
pronounc
decreas
express
observ
treatment
combin
ngml
ngml
compar
treatment
cytokin
separ
fig
remov
cytokin
express
restor
gradual
pretreat
level
data
shown
wherea
addit
fresh
h
decreas
express
background
level
fig
downregul
caus
overal
inhibitori
effect
cell
surfac
protein
express
upregul
mhc
class
express
vero
cell
fig
h
express
vero
cell
follow
time
treatment
gradual
decreas
express
observ
maxim
h
treatment
fig
decreas
express
time
correl
decreas
suscept
sarscov
infect
fig
experi
also
demonstr
display
antivir
activ
administ
least
h
infect
sarscov
fig
contrast
treatment
h
sarscov
infect
reduc
replic
least
log
shown
result
substanti
hypothesi
inhibit
sarscov
replic
downregul
fact
downregul
treatment
gradual
process
express
recov
slowli
cytokin
remov
suggest
downregul
mrna
level
use
taqman
observ
reduc
mrna
level
vero
cell
h
treatment
fig
implic
downregul
cytokin
regul
transcript
level
well
establish
ifn
inhibit
replic
mani
differ
virus
includ
sarscov
haagman
et
al
morgenstern
et
al
sainz
et
al
ifn
bind
receptor
downstream
signal
receptor
block
one
step
viru
life
cycl
hand
induc
protein
may
even
antagon
protect
effect
ifn
lohoff
et
al
gener
cytokin
consid
display
antivir
activ
fact
studi
demonstr
mediat
inhibit
viral
replic
goletti
et
al
lin
et
al
furthermor
express
recombin
ectromelia
viru
vaccinia
viru
exacerb
infect
vivo
administr
recombin
delay
viru
clearanc
influenza
virusinfect
mice
jackson
et
al
moran
et
al
sharma
et
al
studi
demonstr
treatment
vero
cell
decreas
suscept
cell
sarscov
infect
interestingli
express
cell
surfac
downregul
fig
influenc
cytokin
treatment
express
express
determin
treatment
ngml
preincub
neutral
antibodi
b
ngml
c
ngml
ngml
combin
ngml
e
h
vero
cell
incub
h
presenc
ngml
combin
ngml
f
hlaa
b
c
express
vero
cell
treatment
ngml
g
combin
h
dot
line
repres
cytokinetr
cell
thick
line
repres
mocktreat
control
cell
shade
area
repres
background
stain
treatment
therefor
postul
may
decreas
suscept
sarscov
infect
partial
modul
cell
surfac
express
cytokinemedi
downregul
viral
receptor
report
earlier
case
coxsackievirusadenoviru
receptor
downregul
synergist
vitro
vincent
et
al
studi
show
antivir
activ
observ
ad
sarscov
infect
suggest
inhibit
entri
viru
possibl
effect
viral
receptor
line
observ
antivir
effect
hsv
show
antivir
activ
also
util
receptor
subsequ
experi
reveal
express
inde
downregul
confirm
involv
intermedi
antivir
activ
hard
proof
essenti
role
sarscov
infect
compon
reninangiotensin
system
enzymat
cleav
angiotensin
angiotensin
angiotensin
ii
angiotensin
donoghu
et
al
vicker
et
al
sever
studi
report
regul
express
like
relat
enzymat
activ
protein
express
downregul
kidney
hypertens
diabet
rat
crackow
et
al
tikelli
et
al
wherea
upregul
demonstr
block
angiotensin
iireceptor
kidney
rat
pregnanc
human
fail
heart
brosnihan
et
al
crackow
et
al
goulter
et
al
ishiyama
et
al
tikelli
et
al
furthermor
recent
shown
downregul
lung
mice
acut
lung
injuri
includ
sarscov
infect
kuba
et
al
probabl
regul
sever
differ
factor
express
protein
dynam
variou
cell
type
recent
report
express
depend
differenti
state
epithelia
poorli
express
undifferenti
airway
epitheli
cell
abundantli
express
welldifferenti
cell
jia
et
al
interest
studi
effect
express
cell
downregul
cytokinespecif
downregul
express
cytokin
inhibit
sarscov
replic
vivo
vitro
affect
express
vero
cell
data
shown
treatment
vero
cell
hand
also
downregul
suggest
involv
type
ii
receptor
induc
antivir
activ
howev
hypothesi
could
substanti
antibodi
type
ii
receptor
test
reactiv
nonhuman
primat
vero
cell
forc
downregul
express
cytokin
may
reveal
novel
antivir
strategi
sarscov
infect
potenti
addit
cytokin
abl
downregul
express
could
improv
efficaci
base
anti
sarscov
therapi
howev
downregul
may
potenti
neg
effect
sar
pathogenesi
sinc
recent
report
protect
role
acut
lung
failur
mice
imai
et
al
therefor
necessari
explor
consequ
downregul
sar
pathogenesi
import
find
studi
observ
cytokin
modul
express
physiolog
relev
induc
antivir
activ
may
limit
cytokin
probabl
produc
larg
fig
express
sarscov
suscept
differ
time
point
treatment
express
vero
cell
monitor
differ
time
point
treatment
rel
control
cell
suscept
vero
cell
sarscov
monitor
differ
time
point
treatment
ngml
b
shown
number
sarscov
infect
cell
per
well
fig
mrna
level
vero
cell
treatment
ngml
combin
ngml
ngml
compar
mrna
level
untreat
control
cell
mrna
level
untreat
control
cell
cell
repres
fold
chang
gene
express
rel
cell
use
calibr
gapdh
use
endogen
control
quantiti
natur
sarscov
infect
huang
et
al
wong
et
al
howev
vaccin
strategi
util
inactiv
sarscov
subunit
presenc
specif
alum
base
adjuv
may
skew
immun
respons
allow
product
upon
restimul
spruth
et
al
relev
express
modul
pathogenesi
sar
cov
need
investig
vero
cell
atcc
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
sodium
bicarbon
mm
hepe
buffer
unless
state
otherwis
recombin
human
rhu
bd
pharmingen
rhu
rhu
rhu
rhu
peprotech
inc
rhu
roch
ad
cell
cultur
concentr
ngml
h
infect
specif
control
rhu
preincub
neutral
antibodi
ebiosci
min
addit
cell
treatment
done
quadruplet
experi
triplic
experi
vero
cell
grown
plate
infect
tissu
cultur
infect
dose
tcid
sarscov
ad
viru
directli
vero
cell
cultur
h
cell
fix
neutralbuff
formalin
treat
ethanol
min
rt
sarscov
infect
cell
visual
use
purifi
human
igg
convalesc
sar
patient
csl
follow
stain
antibodi
human
igg
link
horseradish
peroxidas
amersham
bioscienc
hsvinfect
cell
stain
use
rabbit
anti
antiserum
follow
stain
antibodi
rabbit
igg
link
horseradish
peroxidas
dako
case
infect
vero
cell
cultur
presenc
absenc
infect
tcid
inoculum
remov
h
replac
fresh
medium
h
supernat
cell
titrat
fresh
vero
cell
antivir
activ
sarscov
determin
plaqu
titrat
vero
cell
grown
plate
presenc
absenc
infect
tcid
sarscov
h
inoculum
remov
fresh
medium
ad
supernat
cultur
taken
h
plaqu
titrat
inocul
fresh
vero
cell
cultur
plate
h
subsequ
cell
wash
cultur
medium
contain
low
melt
point
agaros
ad
plate
incub
day
plaqu
count
well
contain
approxim
plaqu
result
express
pfuml
rtpcr
primer
probe
specif
nucleoprotein
gene
sarscov
use
quantifi
sarscov
infect
cell
describ
earlier
kuiken
et
al
serial
dilut
sarscov
stock
use
standard
mrna
level
determin
use
taqman
gene
express
assay
appli
biosystem
differ
express
repres
fold
chang
gene
express
normal
refer
use
method
livak
schmittgen
housekeep
gene
gapdh
use
refer
cell
use
calibr
sinc
cell
lowest
express
bind
sarscov
protein
analyz
use
flow
cytometri
histag
protein
protein
scienc
incub
cytokinetr
mocktreat
vero
cell
h
follow
invitrogen
stain
detect
bind
protein
vero
cell
without
cytokin
treatment
stain
polyclon
goat
antibodi
r
system
follow
stain
antigoatfitc
antibodi
sigma
control
background
stain
antibodi
cell
incub
normal
goat
serum
mp
biomed
stain
receptor
vero
cell
could
block
solubl
protein
r
system
solubl
ace
protein
r
system
demonstr
specif
antibodi
data
shown
